Release Date: 08/01/21 08:23 Summary: AC8: AusCann Leadership Post CannPal Acquisition Price Sensitive: Yes Download Document 127.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%